|
|
 |
|
Viewing report
|
|
|
|
2010 Trends to Watch: Pharmaceutical Technology
Datamonitor, Dec 2009, Pages: 17
In collaboration with analysts from Healthcare business unit, in this brief Ovum's Pharmaceutical Technology team outlines the key changes in the pharma industry, explains which trends will have the biggest impact, and analyses the implications and opportunities of these developments for both pharmaceutical companies and providers of technologies and services.
Scope
- This brief outlines business issues and technology enablers that are expected to affect the pharmaceutical industry during 2010.
- The report covers developments in North America and Europe.
Highlights of this title
Through research and analysis, Ovum has identified several key trends that will shape the pharma and biotech markets in 2010. Pharma is evolving towards a new business model: Pharma 2.0, new R&D models embrace biotechnology and biomedical research and the future success of pharma relies on the emerging markets.
As the life sciences industry moves into its next phase, technology will play a significant role in its transformation. However, in the short term, there will be some solutions that will take precedence over others.
Key reasons to purchase this title
- Understand the key operational trends to watch during 2010.
- Gain insight into the technologies that pharmaceutical companies must either invest in or extract more value from in 2010.
Customers who bought this item also bought
2011 Trends to Watch: Pharmaceutical Technology
2010 Guide to the Life Sciences Industry for Technology Providers
Biotech M&A and Licensing Strategies - Co-development Agreements are Poised to Increase in the Future to Counter Drying Pipelines
Big Pharma’s New Licensing Strategies
IT Software Tools for Life Science and Drug Discovery R&D
The New Trends of Global Pharmaceutical Outsourcing: New Developments in Strategy, Market, Service and Technology
Pharmaceutical Research and Development (R&D) - Increasing Efficiency through Information Technology and Externalization
Innovative R&D Strategies and Models - Outsourcing, Strategic Partnerships and Licensing to Improve Productivity and Contain Costs
A Global Recession Drives New Business Strategies and Evolving Business Models in the Biopharma Industry
2009 Trends to Watch: Pharmaceutical Technology
|
|
|
|
